CSL889 not checked

CSL Behring

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
1 active
2 in total · 1 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“CSL889 is a solution for infusion to be administered by the IV route.”In the company’s words, NCT06699849 on ClinicalTrials.gov
Tested for
Sickle Cell Disease Vaso-occlusive Crisis
Main trialPhase 2
“This is a phase 2, randomized, multiple-dose, placebo-controlled study designed to evaluate the safety, efficacy, and pharmacokinetics (PK) of CSL889 (human hemopexin) when given intravenously (IV) to adults and adolescents with sickle cell disease (SCD) experiencing vaso-occlusive crises (VOC). The main objectives of the study are to evaluate the safety and tolerability of CSL889 in study participants, and to assess how CSL889 affects the time it takes for VOC to resolve in participants with SCD.”In the company’s words, NCT06699849 on ClinicalTrials.gov
Other names
Hemopexin · human

Other drugs for Sickle Cell Disease Vaso-occlusive Crisis

All 21 drugs for Sickle Cell Disease Vaso-occlusive Crisis

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 2Recruiting 22 Oct 2027 Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Phase 1Completed 24 Jul 2023 Safety of Single Doses of CSL889 in Adult Patients With Sickle Cell Disease
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow CSL889

Following is part of Solo: you see every change to CSL889 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in